Aspergillus fumigatus Detection and Risk Factors in Patients with COPD–Bronchiectasis Overlap
AbstractThe role of Aspergillus fumigatus in the airways of chronic obstructive pulmonary disease (COPD) patients with bronchiectasis is currently unclear. We searched for a sensitive and noninvasive method for A. fumigatus detection in the sputum of COPD patients and addressed potential risk factors for its presence. Induced sputum samples of 18 COPD patients and 17 COPD patients with bronchiectasis were analyzed for the presence of A. fumigatus by culture, galactomannan detection, and PCR. Of the patients with COPD–bronchiectasis overlap, 23.5% had a positive culture for A. fumigatus versus 10.5% of COPD patients without bronchiectasis (p = 0.39). The median sputum galactomannan optical density index was significantly higher in patients with COPD and bronchiectasis compared with patients with COPD alone (p = 0.026) and ranged between the levels of healthy controls and A. fumigatus-colonized cystic fibrosis patients. Both the presence of bronchiectasis and the administration of systemic corticosteroids were associated with sputum galactomannan (p = 0.0028 and p = 0.0044, respectively) and showed significant interaction (p interaction = 0.022). PCR for Aspergillus was found to be a less sensitive method, but was critically dependent on the extraction technique. The higher sputum galactomannan levels suggest a more abundant presence of A. fumigatus in the airways of patients with COPD–bronchiectasis overlap compared with patients with COPD without bronchiectasis, particularly when systemic corticosteroids are administered. View Full-Text
- Supplementary File 1:
PDF-Document (PDF, 117 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Everaerts, S.; Lagrou, K.; Vermeersch, K.; Dupont, L.J.; Vanaudenaerde, B.M.; Janssens, W. Aspergillus fumigatus Detection and Risk Factors in Patients with COPD–Bronchiectasis Overlap. Int. J. Mol. Sci. 2018, 19, 523.
Everaerts S, Lagrou K, Vermeersch K, Dupont LJ, Vanaudenaerde BM, Janssens W. Aspergillus fumigatus Detection and Risk Factors in Patients with COPD–Bronchiectasis Overlap. International Journal of Molecular Sciences. 2018; 19(2):523.Chicago/Turabian Style
Everaerts, Stephanie; Lagrou, Katrien; Vermeersch, Kristina; Dupont, Lieven J.; Vanaudenaerde, Bart M.; Janssens, Wim. 2018. "Aspergillus fumigatus Detection and Risk Factors in Patients with COPD–Bronchiectasis Overlap." Int. J. Mol. Sci. 19, no. 2: 523.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.